TCTR20220930004已完成不适用
Efficacy and safety of 1.5% and 1% pilocarpine eyedrop combined with 0.1% brimonidine compared to 1.25% pilocarpine eyedrop in presbyopia treatment
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 40 Years 至 60 Years（—）
- 性别
- All
入选标准
- •1) Age 40-60 years with VA least 6/6 in both eyes
- •2) Measured by autorefractor +/- 0.5 D and astigmatism does not exceed 0.5 D
- •3) Presbyopia Diagnosed by reading Rosenbaum Near VA at 14 inches, not J1+
排除标准
- •1) Astigmatism more than 0.5 D
- •2) History of glaucoma, cataract, retinal detachment or other eye diseases obscuring vision
- •3) Taking medications such as psychiatric drugs, anticholinergic drugs or other drugs
研究者
相似试验
招募中
3 期
the effect of pilocarpine 1% eye drop on the relative improvement of presbyopiapresbyopia.H52.4PresbyopiaIRCT20240325061363N1Yazd University of Medical Sciences60
招募中
不适用
Treatment efficacy of 0.05% cyclosporine eyedrop on ocular surface changes after anti-glaucoma medication in glaucoma patients.Diseases of the eye and adnexaKCT0007124Keimyung University Dongsan Hospital30
已完成
3 期
Effect of pilocarpine 2% eye drops on treatment resistant oral erosions of pemphigus.CTRI/2017/11/010445IADV
已完成
不适用
Study of the efficacy and safety of pilocarpine hydrochloride for vaginal dryness symptoms associated with atrophic vaginitisvaginal dryness symptoms associated with atrophic vaginitisJPRN-UMIN000017282Department of Obstetrics and Gynecology,Keio university school of medicine50
招募中
不适用
Clinical evaluation for the effects of intraocular tissue plasminogen activator administration in various eye diseasesVarious eye diseasesJPRN-UMIN000015726Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, Japan50